XML 56 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Sale of Aptevo BioTherapeutics - Summary of Reconciliation of Carrying Amounts of Assets and Liabilities and Income (Loss) from Discontinued Operation (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Discontinued Operations And Disposal Groups [Abstract]        
Accounts receivable, net       $ 7,022
Inventories       6,140
Prepaid expenses       3,147
Total current assets, held for sale       16,309
Intangible assets, net       4,420
VAT receivable and deposit       3,045
Total assets held for sale       23,774
Accounts payable and other accrued liabilities       5,043
Royalties payable       2,018
Accrued payroll       654
Other current liabilities       420
Total current liabilities       $ 8,135
Loss from operations $ (2,492) $ (1,580) $ (2,769)  
Gain on sale of Aptevo BioTherapeutics   14,338    
Deferred payment from Medexus   140    
Income (loss) from discontinued operations $ (2,492) $ 12,898 $ (2,769)